IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis

Abstract Background Interleukin-6 (IL-6) plays a central role in sepsis-induced cytokine storm involving immune hyperactivation and early neutrophil activation. Programmed death protein-1 (PD-1) is associated with sepsis-induced immunosuppression and lymphocyte apoptosis. However, the effects of sim...

Full description

Saved in:
Bibliographic Details
Main Authors: Song I Lee, Na Young Kim, Chaeuk Chung, Dongil Park, Da Hyun Kang, Duk Ki Kim, Min-Kyung Yeo, Pureum Sun, Jeong Eun Lee
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Immunology
Subjects:
Online Access:https://doi.org/10.1186/s12865-024-00679-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594818782461952
author Song I Lee
Na Young Kim
Chaeuk Chung
Dongil Park
Da Hyun Kang
Duk Ki Kim
Min-Kyung Yeo
Pureum Sun
Jeong Eun Lee
author_facet Song I Lee
Na Young Kim
Chaeuk Chung
Dongil Park
Da Hyun Kang
Duk Ki Kim
Min-Kyung Yeo
Pureum Sun
Jeong Eun Lee
author_sort Song I Lee
collection DOAJ
description Abstract Background Interleukin-6 (IL-6) plays a central role in sepsis-induced cytokine storm involving immune hyperactivation and early neutrophil activation. Programmed death protein-1 (PD-1) is associated with sepsis-induced immunosuppression and lymphocyte apoptosis. However, the effects of simultaneous blockade of IL-6 and PD-1 in a murine sepsis model are not well understood. Results In this study, sepsis was induced in male C57BL/6 mice through cecal ligation and puncture (CLP). IL-6 blockade, PD-1 blockade, or combination of both was administered 24 h after CLP. Peripheral blood count, cytokine level, lymphocyte apoptosis in the spleen, neutrophil infiltration in the lungs and liver, and survival rate were measured. The mortality rate of the IL-6/PD-1 group was lower, though not statistically significant (p = 0.164), than that of CLP mice (75.0% vs. 91.7%). The IL-6/PD-1 group had lower neutrophil percentage and platelet count compared with the CLP group; no significant difference was observed in other cytokine levels. The IL-6/PD-1 group also showed reduced T lymphocyte apoptosis in the spleen and decreased neutrophil infiltration in the liver and lungs. Conclusions IL-6/PD-1 dual blockade reduces neutrophil infiltration, lymphocyte apoptosis, and bacterial burden while preserving tissue integrity in sepsis. Although the improvement in survival was not statistically significant, these findings highlight its potential as a therapeutic approach in sepsis.
format Article
id doaj-art-2ed5bf419bfb41218c6453952de0cc31
institution Kabale University
issn 1471-2172
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Immunology
spelling doaj-art-2ed5bf419bfb41218c6453952de0cc312025-01-19T12:16:35ZengBMCBMC Immunology1471-21722025-01-0126111310.1186/s12865-024-00679-zIL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsisSong I Lee0Na Young Kim1Chaeuk Chung2Dongil Park3Da Hyun Kang4Duk Ki Kim5Min-Kyung Yeo6Pureum Sun7Jeong Eun Lee8Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalDepartment of Pathology, Chungnam National University School of MedicineCollege of Medicine, Research Institute for Medical Sciences, Chungnam National UniversityDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University HospitalAbstract Background Interleukin-6 (IL-6) plays a central role in sepsis-induced cytokine storm involving immune hyperactivation and early neutrophil activation. Programmed death protein-1 (PD-1) is associated with sepsis-induced immunosuppression and lymphocyte apoptosis. However, the effects of simultaneous blockade of IL-6 and PD-1 in a murine sepsis model are not well understood. Results In this study, sepsis was induced in male C57BL/6 mice through cecal ligation and puncture (CLP). IL-6 blockade, PD-1 blockade, or combination of both was administered 24 h after CLP. Peripheral blood count, cytokine level, lymphocyte apoptosis in the spleen, neutrophil infiltration in the lungs and liver, and survival rate were measured. The mortality rate of the IL-6/PD-1 group was lower, though not statistically significant (p = 0.164), than that of CLP mice (75.0% vs. 91.7%). The IL-6/PD-1 group had lower neutrophil percentage and platelet count compared with the CLP group; no significant difference was observed in other cytokine levels. The IL-6/PD-1 group also showed reduced T lymphocyte apoptosis in the spleen and decreased neutrophil infiltration in the liver and lungs. Conclusions IL-6/PD-1 dual blockade reduces neutrophil infiltration, lymphocyte apoptosis, and bacterial burden while preserving tissue integrity in sepsis. Although the improvement in survival was not statistically significant, these findings highlight its potential as a therapeutic approach in sepsis.https://doi.org/10.1186/s12865-024-00679-zActivation, LymphocyteActivation, NeutrophilInterleukin 6Sepsis
spellingShingle Song I Lee
Na Young Kim
Chaeuk Chung
Dongil Park
Da Hyun Kang
Duk Ki Kim
Min-Kyung Yeo
Pureum Sun
Jeong Eun Lee
IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
BMC Immunology
Activation, Lymphocyte
Activation, Neutrophil
Interleukin 6
Sepsis
title IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
title_full IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
title_fullStr IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
title_full_unstemmed IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
title_short IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis
title_sort il 6 and pd 1 antibody blockade combination therapy regulate inflammation and t lymphocyte apoptosis in murine model of sepsis
topic Activation, Lymphocyte
Activation, Neutrophil
Interleukin 6
Sepsis
url https://doi.org/10.1186/s12865-024-00679-z
work_keys_str_mv AT songilee il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT nayoungkim il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT chaeukchung il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT dongilpark il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT dahyunkang il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT dukkikim il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT minkyungyeo il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT pureumsun il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis
AT jeongeunlee il6andpd1antibodyblockadecombinationtherapyregulateinflammationandtlymphocyteapoptosisinmurinemodelofsepsis